Clinical Trial Update: Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years [NA]

View source ↗

Summary

A clinical trial assessing immune response to a Hepatitis B booster given 20-23 years after initial vaccination has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatitis B Vaccination | NA | Status: TERMINATED